The marijuana industry has become a big business in the United States, thanks to the War on Drugs and a new generation of doctors who have embraced the drug as a medical treatment.
But there are many, many people in the marijuana industry who do not believe marijuana should be legalized, and they’re fighting to stop the trend.
Their fight has been backed by the U.S. Drug Enforcement Administration (DEA), which has seized marijuana companies and people involved in them on drug charges and shut down dozens of marijuana-related businesses in the U, Europe, Canada, Australia and New Zealand.
The DEA has also accused some marijuana companies of illegally importing marijuana, and in July the agency seized over $100 million worth of the drug from California-based Growlers Inc., a company owned by an Australian entrepreneur who was facing federal drug charges in the states of California and Washington.
But a number of marijuana companies are fighting back, including the largest marijuana producer in the world, Canopy Growth Corporation.
Canopy is a marijuana-growing and manufacturing company with more than 20,000 employees and $2 billion in revenue.
The company has invested in research and development in the fields of bioengineering, genetics and marijuana-based medicine.
Its CEO, Bruce Linton, has been outspoken against the War On Drugs and its harsh enforcement of federal law, and he has been a vocal critic of the U:S.
government’s drug war.
“This is a war on the medical marijuana industry,” Linton said in an interview with the Huffington Post.
“It’s like the Soviet Union, but in the West.
We have all the problems, the war is going on.
It’s a complete and total disaster.”
Linton has a history of outspokenness.
He became a vocal supporter of marijuana legalization in 2013, when he co-founded a group called Indivisible, which calls for marijuana to be legalized and taxed like alcohol.
And he has a long history of defending marijuana users and their rights to use the drug.
“People are saying we’re going to lose our way of life if we continue to do the same thing,” Lenton told the Associated Press.
“And we’re not going to get anywhere unless we get the message that people have rights.
We’re not a criminal organization.”
Londons cannabis business, Canvas Growers, has spent $4.5 million on research and medical cannabis products since 2015.
The firm is a major player in California, which is the only U.K. state where marijuana is legal.
“We’ve invested in this space for a long time,” Londontons chief executive officer, Alex Stoner, told the AP.
“I’ve always believed in this business.
I’m passionate about this industry and I believe in the importance of medical marijuana and the research that goes into it.”
Stoner added that Canvas has received a great deal of media attention in the last year, and that he expects a major boost in sales when the U government starts enforcing marijuana laws more aggressively.
“There’s a huge appetite for marijuana in the States, particularly in California,” Stoner said.
“But we also have a strong market presence in other parts of the world.
So it’s exciting for the market to be on the front page of the Wall Street Journal, for example.”
The marijuana business is a relatively new one in the medical cannabis industry, but it is expanding rapidly.
A 2014 study published in the journal The Lancet estimated that there were 1.6 million marijuana businesses in 20 U.N. member states, and the number is growing.
According to an estimate from the World Health Organization, there are more than 150 million people worldwide who are living with a medical condition that is treatable with marijuana.
Linton believes the cannabis industry has a bright future.
“What’s going to be a really important part of that is the development of the technology,” he said.
A growing number of medical and scientific experts agree with Linton.
The Drug Enforcement Agency has already shut down a number to medical marijuana companies, including Canopy.
And there are a number that are still operating despite the DEA seizure of their assets.
In September, the DEA raided the company of a Colorado man named James Roush, a medical marijuana grower who had been facing federal charges in Arizona.
Rousher was charged with a number federal crimes, including conspiring to distribute and possess with intent to distribute more than 50 grams of marijuana, as well as distributing more than 500 grams of hash oil, a derivative of marijuana that has been used as a medicinal ingredient in a variety of traditional and herbal forms.
The federal government claimed Rousham was acting on behalf of an organized crime group, but the U of S Attorney’s Office for the Southern District of Arizona disagreed.
The U. S. Attorney’s office claimed that Rousheh was not acting on his own behalf,